D

DNTH

DNTH

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
DNTH Live QuoteReal-time
$84.83
+$6.73(+8.62%)1M
Day Range$83.25 – $87.12
Open$84.33
Previous Close$83.98
Volume896.8K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$4.73B
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-3.94
Price to Book3.9
Dividend Yield0.65%
Beta (Volatility)0.26
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $84.83 (60%)
Low: $35.84High: $117.88
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$139.25-7.2% upside

Insider Buys

0

$0

Insider Sales

22

$83.13M

Total Volume

$83.13M

38 transactions

Net Activity

$83.13M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
15CONFIDENCE

Sentiment Rating

Heavy Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
G
1

Garcia Marino

CEO, Pres

0 buys2 sells

$27.96M total

S
2

Savitz Ryan

EVP, CFO, CBO

0 buys6 sells

$26.22M total

R
3

Randhawa Simrat

EVP, Head of R, D

0 buys4 sells

$15.00M total

C
4

Carr Edward

CHIEF ACCOUNTING OFFICER

0 buys2 sells

$5.59M total

V
5

Veness Adam M

SVP, GC, Sec.

0 buys2 sells

$4.63M total

Trading History
DNTH insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 9, 2026

1 weeks ago

Savitz Ryan

EVP, CFO, CBO

CFO
Sell124.0K$90.52$11.23M

Sep 17, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-20000.00$0

Sep 17, 2026

2 months ago

Carr Edward

CHIEF ACCOUNTING OFFICER

C-Level
Sell20.0K$101.38$2.03M

Sep 1, 2026

2 months ago

Randhawa Simrat

EVP, Head of R, D

EVP
Sell23.1K$106.41$2.46M

Sep 1, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell4.0K$-23124.00$0

Aug 19, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-2778.00$0

Aug 19, 2026

3 months ago

Read Simon

Dir

Director
Sell2.8K$117.55$327K

Aug 10, 2026

3 months ago

Read Simon

Dir

Director
Sell2.8K$109.55$304K

Aug 7, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-20000.00$0

Aug 10, 2026

3 months ago

McGeorge Anne

Dir

Director
Sell7.8K$109.01$845K

Aug 10, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-7750.00$0

Aug 7, 2026

3 months ago

Veness Adam M

SVP, GC, Sec.

SVP
Sell20.0K$110.44$2.21M

Aug 7, 2026

3 months ago

Garcia Marino

CEO, Pres

CEO
Sell166.0K$108.11$17.95M

Jul 9, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-31249.00$0

Jul 9, 2026

4 months ago

Savitz Ryan

EVP, CFO, CBO

CFO
Sell31.2K$101.03$3.16M

Jun 17, 2026

5 months ago

Veness Adam M

SVP, GC, Sec.

SVP
Sell30.0K$80.80$2.42M

Jun 17, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-30000.00$0

Jun 1, 2026

5 months ago

Randhawa Simrat

EVP, Head of R, D

EVP
Sell26.5K$90.62$2.40M

Jun 1, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell4.0K$-26530.00$0

May 8, 2026

6 months ago

Soteropoulos Paula

Dir

Director
Sell599$85.47$51K

May 8, 2026

6 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-599.00$0

Apr 9, 2026

7 months ago

Savitz Ryan

EVP, CFO, CBO

CFO
Sell8.2K$89.84$739K

Apr 9, 2026

7 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-8224.00$0

Mar 31, 2026

7 months ago

Savitz Ryan

EVP, CFO, CBO

CFO
Sell114.4K$83.00$9.49M

Mar 31, 2026

7 months ago

Soteropoulos Paula

Dir

Director
Sell599$80.11$48K

Mar 31, 2026

7 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-114367.00$0

Mar 24, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-27594.00$0

Mar 24, 2026

8 months ago

Soteropoulos Paula

Dir

Director
Sell27.6K$78.05$2.15M

Mar 12, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-122918.00$0

Mar 12, 2026

8 months ago

Garcia Marino

CEO, Pres

CEO
Sell122.9K$81.49$10.02M

Mar 12, 2026

8 months ago

Carr Edward

CHIEF ACCOUNTING OFFICER

C-Level
Sell43.7K$81.49$3.56M

Mar 12, 2026

8 months ago

Randhawa Simrat

EVP, Head of R, D

EVP
Sell33.8K$81.48$2.76M

Dec 4, 2025

11 months ago

Savitz Ryan

CFO, CBO

CFO
Sell20.0K$45.18$904K

Dec 4, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-20000.00$0

Nov 13, 2025

12 months ago

Randhawa Simrat

EVP, Head of R, D

EVP
Sell196.5K$37.55$7.38M

Nov 13, 2025

12 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell4.0K$-196538.00$0

Sep 9, 2025

14 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-20000.00$0

Sep 9, 2025

14 months ago

Savitz Ryan

CFO, CBO

CFO
Sell20.0K$35.00$700K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
DNTH Buy Conviction0%
Industry Rank#131 of 570
Volume Contribution0.5%
Total Industry Activity$16.44B

DNTH has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. DNTH ranks #131 in insider activity out of 570 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for DNTH

Over the last 90 days, corporate insiders at DNTH (DNTH) engaged in a total of 38 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 22 were sales. The total volume of insider trading reached $83.13M.

The net insider activity for DNTH shows a net selling bias of $83.13M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Garcia Marino (CEO, Pres), who traded 166.0K shares valued at $17.95M on Aug 7, 2026.

Live Market News & Developments
Aggregated real-time headlines for DNTH (DNTH)
6 updates

Dianthus Therapeutics (DNTH) Stock May Look Stretched As Pipeline Progress Draws Focus

Yahoo Finance10d ago

DNTH - Dianthus Therapeutics Inc Stock Price and Quote

Finviz176d ago

Dianthus Therapeutics (NASDAQ:DNTH) Shares Cross Below 50-Day Moving Average - Here's What Happened

MarketBeatYesterday

Can Dianthus Therapeutics (DNTH) Stay Undervalued Following Its $500 Million Stock Offering?

Yahoo Finance56d ago

$DNTH stock is down 15% today. Here's what we see in our data.

Quiver Quantitative162d ago

Dianthus (NASDAQ: DNTH) officer set to sell 20,000 shares

Stock Titan63d ago

FAQs About DNTH Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for DNTH.

Based on SEC Form 4 disclosures, the Insider Confidence Score for DNTH is currently 15/100, which reflects a heavy distribution bias. This calculation accounts for a total of 0 purchases and 22 sales by company executives over the last 90 days.

The CEO Conviction Index for DNTH is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.